STEPHANIE BLACKMORE: Open Payments
NPI 1366052771 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 50 payments from 12 companies in 2025. Trend: 2023 $473 · 2024 $372 · 2025 $1,143
Food & beverage: $1,111Education: $32
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $269 |
| Novo Nordisk Inc | 12 | $227 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Boston Scientific Corporation | 2 | $61 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| PFIZER INC. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
Products named: REPATHA, LifeVest, Wegovy, OTEZLA, AIRSUPRA, BREZTRI, DUPIXENT, Ozempic.
Industry payments across AZ — which companies pay providers there.
